Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Hutchmed China Ltd ADR (NQ: HCM ) 17.26 -0.63 (-3.52%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Hutchmed China Ltd ADR < Previous 1 2 3 4 5 6 7 8 Next > HUTCHMED Completes Patient Enrollment of a Bridging Study of Tazemetostat in Patients with Relapsed/Refractory Follicular Lymphoma in China September 11, 2023 From HUTCHMED (China) Limited Via GlobeNewswire Tesla, Crinetics Pharmaceuticals And Other Big Stocks Moving Higher In Monday's Pre-Market Session September 11, 2023 U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording gains in today’s pre-market trading session. Via Benzinga HUTCHMED Receives Breakthrough Therapy Designation in China for Savolitinib for Gastric Cancer August 28, 2023 From HUTCHMED (China) Limited Via GlobeNewswire Week In Review: A Consortium Of China Drug Distributors Want To Acquire Poland's Neuca August 26, 2023 China’s drug distributors are in the hunt to acquire Poland’s Neuca, a company with a 32% market share of Poland’s pharmaceutical distribution business. The consortium of China’s drug distributors may... Via Talk Markets Hutchmed's Candidate Achieves Main Goal In China's Rare Blood Disorder Study August 21, 2023 HUTCHMED (China) Limited's (NASDAQ: HCM) pivotal Phase 3 trial ESLIM-01 evaluating the investigational use of sovleplenib met its primary endpoint of durable response rate and all secondary endpoints... Via Benzinga HUTCHMED Announces that the Sovleplenib Phase III ESLIM-01 Study Met Its Primary Endpoint in Primary Immune Thrombocytopenia in China August 20, 2023 From HUTCHMED (China) Limited Via GlobeNewswire 12 Health Care Stocks Moving In Monday's Pre-Market Session August 07, 2023 Via Benzinga Why Krystal Biotech Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session August 07, 2023 Gainers Vistagen Therapeutics, Inc. (NASDAQ: VTGN) shares jumped 747.6% to $14.24 after the company announced its Phase 3 PALISADE-2 trial evaluating the efficacy, safety, and tolerability of... Via Benzinga Why Kosmos Energy Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket August 07, 2023 Gainers Save Foods, Inc. (NASDAQ: SVFD) shares surged 76.6% to $1.13 in pre-market trading after gaining 15% on Friday. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday August 07, 2023 It's time to start off the week with a breakdown of the biggest pre-market stock movers worth reading about on Monday morning! Via InvestorPlace Sohu.com, Cloudflare And Other Big Stocks Moving Lower In Monday's Pre-Market Session August 07, 2023 U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session. HUTCHMED (China) Limited (NYSE: HCM) shares dipped 14.1% to... Via Benzinga Caterpillar, Oshkosh, AudioCodes And Other Big Stocks Moving Higher On Tuesday August 01, 2023 U.S. stocks traded lower, with the Nasdaq Composite falling around 70 points on Tuesday. Here are some big stocks recording gains in today’s session. American Superconductor Corporation (NASDAQ: AMSC)... Via Benzinga Why Aaron's Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session August 01, 2023 Gainers Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) shares gained 188.8% to $4.13. The stock is now on the Regulation SHO "threshold security" list. Via Benzinga HUTCHMED Reports 2023 Interim Results and Provides Business Updates July 31, 2023 From HUTCHMED (China) Limited Via GlobeNewswire Earnings Scheduled For July 31, 2023 July 31, 2023 Companies Reporting Before The Bell • Immunogen (NASDAQ:IMGN) is estimated to report quarterly loss at $0.16 per share on revenue of $42.84 million. Via Benzinga HUTCHMED Receives Breakthrough Therapy Designation in China for Fruquintinib Combination with Sintilimab for Treatment of Advanced Endometrial Cancer, and Completes Enrollment of Registration Study July 19, 2023 From HUTCHMED (China) Limited Via GlobeNewswire HUTCHMED Announces Changes to Board of Directors and Technical Committee July 13, 2023 Ms Ling Yang to replace Mr Lefei Sun as Non-executive Director; Professor Solange Peters appointed as Special Advisor to the Technical Committee From HUTCHMED (China) Limited Via GlobeNewswire HUTCHMED Initiates Phase I Study of its novel SHP2 inhibitor HMPL-415 for Advanced Malignant Solid Tumors in China July 09, 2023 From HUTCHMED (China) Limited Via GlobeNewswire HUTCHMED to Announce 2023 Half-Year Financial Results June 26, 2023 From HUTCHMED (China) Limited Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's Intraday Session June 20, 2023 Via Benzinga HUTCHMED and Takeda Announce Publication of Phase III FRESCO-2 Results in The Lancet June 15, 2023 From HUTCHMED (China) Limited Via GlobeNewswire Takeda and HUTCHMED Announce Marketing Authorization Application of Fruquintinib for Previously Treated Metastatic Colorectal Cancer Validated by the European Medicines Agency June 15, 2023 From HUTCHMED (China) Limited Via GlobeNewswire HUTCHMED Highlights Presentations for Hematological Malignancy Programs at the 2023 EHA and ICML Meetings June 09, 2023 From HUTCHMED (China) Limited Via GlobeNewswire Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session May 30, 2023 Gainers QualTek Services Inc. (NASDAQ: QTEK) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy. Via Benzinga Skyline Champion, Atea Pharmaceuticals And Other Big Stocks Moving Lower On Tuesday May 30, 2023 U.S. stocks traded mixed, with the Dow Jones dropping over 100 points on Tuesday. Here are some big stocks recording losses in today’s session. Via Benzinga 10 Stocks Reacting To April PCE: Marvell Technology Leads The Rally May 26, 2023 Via Benzinga Takeda and HUTCHMED Announce New Drug Application (NDA) for Fruquintinib for Treatment of Previously Treated Metastatic Colorectal Cancer Granted Priority Review May 25, 2023 From HUTCHMED (China) Limited Via GlobeNewswire HUTCHMED Highlights Presentations at the 2023 ASCO Annual Meeting May 25, 2023 From HUTCHMED (China) Limited Via GlobeNewswire Deutsche Bank ADR Investor Conference: Presentations Now Available for Online Viewing May 18, 2023 Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com From Virtual Investor Conferences Via GlobeNewswire International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 16th and 17th, 2023 May 15, 2023 From Virtual Investor Conferences Via GlobeNewswire < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.